¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2018³â Á¦25Â÷ ¿µ³²½ÅÀ庴¿¬±¸È¸ & KSN Update 2018 : 2018-11-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2018³â Á¦25Â÷ ¿µ³²½ÅÀ庴¿¬±¸È¸ & KSN Update 2018 : 2018-11-17
±³À°ÀÏÀÚ : 2018-11-17
±³À°Àå¼Ò : ´ë±¸±¤¿ª½Ã ¿µ³²ÀÌ°ø´ëÇб³ õ¸¶½ºÄù¾î 2Ãþ ½Ãû°¢½Ç  
±³À°ÁÖÁ¦ : 2018³â Á¦25Â÷ ¿µ³²½ÅÀ庴¿¬±¸È¸ & KSN Update 2018
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ë±¸.°æºÏ Áöȸ  
´ã´çÀÚ : °­¼®ÈÖ
¿¬¶ôó : 02-000-0000  
À̸ÞÀÏ : kangkang@ynu.ac.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 13:30~13:55 Treatment of IgA nephropathy: Review of guideline and summary of recent studies  °­¼®ÈÖ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 13:55~14:20 Primary MGN: Recent insights into pathogenesis and treatment  ±ÇÇõ¿ë(BHSÇѼ­º´¿ø) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 14:20~14:45 Potassium control in CKD and ESRD: The old, the current, and the future  °­°Ç¿ì(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 14:45~15:10 Direct oral anticoagulation in advanced kidney disease: An update  ±èÅÂÈñ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 15:25~15:50 What¡¯s new in DKD?  ¹ÚöÈÖ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 15:50~16:15 Guideline for preventing of infections in hemodialysis center  ÀÌ¿µ±â(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 16:15~16:40 What¡¯s the better choice between HD with medium cut-off dialyzer & on-line HDF?  Á¶ÀåÈñ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 16:40~17:05 Virtual reality-based training in Nephrology: has the future arrived?  ±è¼º±Õ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 17:20~17:45 Disaster management: lessons learned from MERS and earthquake  À¯°æµ·(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 17:45~18:10 BP management in CKD patients: a review of recent guidelines  ÀåÇÏ´Ï(°æ»óÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2018³â Á¦25Â÷ ¿µ³²½ÅÀ庴¿¬±¸È¸ & KSN Update 2018 : 2018-11-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼÒÈ­±âÇÐȸ Asian Pacific Digestive Week(APDW 2018) in conjunction with the 2nd Korea Digestive Disease Week (KDDW 2018) : 2018-11-17
´ÙÀ½±Û ºÐ´ç¼­¿ï´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú Åä¿äȸ : 2018-11-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
152 °æ±â Çϳ²½Ã ÀÇ»çȸ ¿¬¼ö°­ÁÂ(Ç÷°ü¼ºÄ¡¸Å, °¨¿°³»°ú °¨¿°Áúȯ) : 2018-08-30 0 2,099 2018-07-28
151 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø °¢¸· Áúȯ : 2018-08-29 0 770 2018-07-28
150 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø Ȳ¹ÝºÎÁ¾ ¹× Ȳ¹Ýº¯¼º : 2018-08-28 0 698 2018-07-28
149 ´ë±¸ ´ëÇѾȰúÇÐȸ 2018³â ´ë±¸ °æºÏ ¾È°ú Áöȸ Á¤±â ¿¬¼ö±³À° : 2018-08-28 0 729 2018-07-28
148 ºÎ»ê ½Å°æ¿µ»óÀÇÇÐÀÇ ÇмúÁõ·Ê¹ßÇ¥ : 2018-08-28 0 324 2018-07-28
147 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ Á¤±âÁý´ãȸ : 2018-08-27 0 572 2018-07-28
146 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇа­Á : 2018-08-26 0 623 2018-07-28
145 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Cadaver Workshop : 2018-08-26 0 681 2018-07-28
144 ¼­¿ï °³¿ø 50Áֳ⠱â³ä Á¦ 9ȸ °­ºÏ»ï¼ºº´¿ø ´ç´¢Ç÷°ü¼¾ÅÍ ¿¬¼ö°­Á -´ç´¢º´ °ü¸® ¹× ÇÕº´Áõ ¿¹¹æÀ» À§ÇÑ 100³â ´ë°è : 2018-08-26 0 973 2018-07-28
143 ´ëÀü ´ëÇÑ°»³â±âÇÐȸ 2018 ÇÏ°è¿öÅ©¼¥ : 2018-08-26 0 661 2018-07-28
142 ¼­¿ï 2018³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦21Â÷ °ñ´Ù°øÁõ ¿¬¼ö°­Á : 2018-08-26 0 367 2018-07-28
141 ¼­¿ï Á¦16Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2018-08-26 0 513 2018-07-28
140 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease (Day 2) : 2018-08-26 0 378 2018-07-28
139 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ ¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø À̺ñÀÎÈÄ°ú 50Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2018-08-26 0 513 2018-07-28
138 ¼­¿ï Á¦14ȸ ÀÓ»óÀÌ°úÇм¼¹Ì³ª(´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ&´ëÇÑÀÌÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-26 0 663 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷